Published in Purinergic Signal on June 09, 2009
P2X7 receptors mediate deleterious renal epithelial-fibroblast cross talk. Am J Physiol Renal Physiol (2010) 1.57
Activation of P2X receptors induces apoptosis in human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2011) 0.91
Purinergic signalling in the kidney in health and disease. Purinergic Signal (2013) 0.84
Visualization of Calcium Dynamics in Kidney Proximal Tubules. J Am Soc Nephrol (2015) 0.83
Cryopyrin activates the inflammasome in response to toxins and ATP. Nature (2006) 18.74
The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science (1996) 7.10
Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity (2001) 4.23
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain (2005) 3.37
Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol (2002) 2.71
Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol (2000) 2.56
A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol (2004) 2.40
Purinergic signalling: ATP release. Neurochem Res (2001) 2.33
ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J Biol Chem (2000) 2.16
Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am J Physiol (1999) 1.94
Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors. J Neurosci (2003) 1.81
P2X7 receptors in the nervous system. Prog Neurobiol (2006) 1.79
cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol (2000) 1.76
Reanalysis of P2X7 receptor expression in rodent brain. J Neurosci (2004) 1.64
Antagonism of endogenous putative P2Y receptors reduces the growth of MDCK-derived cysts cultured in vitro. Am J Physiol Renal Physiol (2006) 1.63
Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med (1997) 1.62
The role of the purinergic P2X7 receptor in inflammation. J Inflamm (Lond) (2007) 1.50
A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem (2005) 1.47
Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes. J Leukoc Biol (1998) 1.45
Identification and characterization of splice variants of the human P2X7 ATP channel. Biochem Biophys Res Commun (2005) 1.43
The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes. Glia (2005) 1.42
The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors. Kidney Int (2004) 1.41
The pattern of distribution of selected ATP-sensitive P2 receptor subtypes in normal rat kidney: an immunohistological study. Cells Tissues Organs (2003) 1.26
P2X7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol (2004) 1.21
Ecto-5'-nucleotidase: localization in rat kidney by light microscopic histochemical and immunohistochemical methods. J Histochem Cytochem (1989) 1.20
Induction of proliferation and apoptotic cell death via P2Y and P2X receptors, respectively, in rat glomerular mesangial cells. Kidney Int (2000) 1.20
The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. Kidney Int (2006) 1.19
Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc Natl Acad Sci U S A (1989) 1.19
ATP release mechanisms, ATP receptors and purinergic signalling along the nephron. Clin Exp Pharmacol Physiol (2001) 1.17
Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis (1997) 1.16
Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. J Invest Dermatol (2003) 1.16
P2X7 receptor activates extracellular signal-regulated kinases ERK1 and ERK2 independently of Ca2+ influx. Biochem J (2003) 1.13
Cellular localization of P2Y(2) purinoceptor in rat renal inner medulla and lung. Am J Physiol Renal Physiol (2000) 1.12
Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys. Am J Physiol Renal Physiol (2002) 1.12
ATP release mechanisms in primary cultures of epithelia derived from the cysts of polycystic kidneys. J Am Soc Nephrol (1999) 1.12
Intraluminal ATP concentrations in rat renal tubules. J Am Soc Nephrol (2006) 1.10
Stimulation by extracellular ATP and UTP of the mitogen-activated protein kinase cascade and proliferation of rat renal mesangial cells. Br J Pharmacol (1994) 1.10
Immunolocalization of ectonucleotidases along the rat nephron. Am J Physiol Renal Physiol (2005) 1.08
Nucleotides regulate NaCl transport in mIMCD-K2 cells via P2X and P2Y purinergic receptors. Am J Physiol (1999) 1.08
Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis. Nephrol Dial Transplant (2006) 1.06
Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. J Immunol (2008) 1.06
ATP stimulates Cl- secretion and reduces amiloride-sensitive Na+ absorption in M-1 mouse cortical collecting duct cells. J Physiol (2000) 1.06
Functional expression and apical localization of the cystic fibrosis transmembrane conductance regulator in MDCK I cells. Biochem J (1997) 1.05
Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am J Physiol Renal Physiol (2007) 1.05
Identification of a voltage-dependent anion channel in the apical membrane of a Cl(-)-secretory epithelium (MDCK). Pflugers Arch (1985) 1.05
Axial distribution and characterization of basolateral P2Y receptors along the rat renal tubule. Kidney Int (2000) 1.03
Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. Kidney Int (2004) 1.03
Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells. Am J Physiol (1995) 1.03
A role for CFTR in human autosomal dominant polycystic kidney disease. Am J Physiol (1996) 1.02
Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells. Br J Pharmacol (2001) 0.99
P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. Am J Physiol Gastrointest Liver Physiol (2005) 0.97
The isolated polycystin-1 cytoplasmic COOH terminus prolongs ATP-stimulated Cl- conductance through increased Ca2+ entry. Am J Physiol Renal Physiol (2003) 0.97
Ectonucleotidases in the kidney. Purinergic Signal (2009) 0.96
Stimulation of Cl- secretion by exogenous ATP in cultured MDCK epithelial monolayers. Biochim Biophys Acta (1981) 0.95
ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Lett (2004) 0.94
ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am J Respir Cell Mol Biol (1999) 0.93
Ecto-nucleotidases and nucleoside transporters mediate activation of adenosine receptors on hippocampal mossy fibers by P2X7 receptor agonist 2'-3'-O-(4-benzoylbenzoyl)-ATP. J Neurosci (2004) 0.92
The luminal P2Y receptor in the isolated perfused mouse cortical collecting duct. J Am Soc Nephrol (2000) 0.92
Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia. J Neurochem (2005) 0.92
Characterization of a functional P2X(7)-like receptor in cerebellar granule neurons from P2X(7) knockout mice. FEBS Lett (2005) 0.91
P2Y receptors present in the native and isolated rat glomerulus. Nephron Physiol (2004) 0.91
Effects of extracellular nucleotides on renal tubular solute transport. Purinergic Signal (2009) 0.90
The P2X7 ATP receptor modulates renal cyst development in vitro. Biochem Biophys Res Commun (2004) 0.90
P2Y-receptors stimulating the proliferation of human mesangial cells through the MAPK42/44 pathway. Br J Pharmacol (2003) 0.89
The P2X7 receptor is a candidate product of murine and human lupus susceptibility loci: a hypothesis and comparison of murine allelic products. Arthritis Res Ther (2005) 0.89
Expression of polycystin-1 C-terminal fragment enhances the ATP-induced Ca2+ release in human kidney cells. Biochem Biophys Res Commun (2003) 0.89
P2X(7) receptors are expressed during mouse nephrogenesis and in collecting duct cysts of the cpk/cpk mouse. Exp Nephrol (2002) 0.89
P2Y2 receptor polymorphisms and haplotypes in cystic fibrosis and their impact on Ca2+ influx. Pharmacogenet Genomics (2006) 0.88
Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis. Pharmacol Ther (2006) 0.87
Extracellular ATP activates ERK1/ERK2 via a metabotropic P2Y1 receptor in a Ca2+ independent manner in differentiated human skeletal muscle cells. Biochem Pharmacol (2006) 0.87
P2Y1 gene deficiency protects from renal disease progression and capillary rarefaction during passive crescentic glomerulonephritis. J Am Soc Nephrol (2007) 0.87
A regulatory role of polycystin-1 on cystic fibrosis transmembrane conductance regulator plasma membrane expression. Cell Physiol Biochem (2006) 0.87
Ca2+ and cAMP-activated Cl- conductances mediate Cl- secretion in a mouse renal inner medullary collecting duct cell line. J Physiol (2000) 0.87
Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease. Cells Tissues Organs (2004) 0.86
Extracellular ATP promotes cellular growth of renal inner medullary collecting duct cells mediated via P2u receptors. Nephron (1997) 0.84
The isolated C-terminus of polycystin-1 promotes increased ATP-stimulated chloride secretion in a collecting duct cell line. Clin Sci (Lond) (2003) 0.84
The cystic fibrosis transmembrane regulator (CFTR) in the kidney. An Acad Bras Cienc (2000) 0.82
Oxygen/glucose deprivation increases the integration of recombinant P2X7 receptors into the plasma membrane of HEK293 cells. Toxicology (2007) 0.79
Regulation of transepithelial ion transport by two different purinoceptors in the apical membrane of canine kidney (MDCK) cells. Br J Pharmacol (1995) 0.79
Cl- secretion in ATP-treated renal epithelial C7-MDCK cells is mediated by activation of P 2Y1 receptors, phospholipase A2 and protein kinase A. J Physiol (2005) 0.78
Role of ATP in DNA synthesis of renal proximal tubule cells: involvement of calcium, MAPKs, and CDKs. Am J Physiol Renal Physiol (2006) 0.78
Extracellular ATP augments mesangial cell growth induced by multiple growth factors. Nephrol Dial Transplant (1995) 0.76
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int (2009) 4.61
Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat Struct Mol Biol (2010) 3.75
Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42. Biochemistry (2006) 1.88
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int (2009) 1.78
Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis (2012) 1.62
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica (2009) 1.49
Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabetes Care (2009) 1.49
Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med (2003) 1.35
Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int (2011) 1.24
P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. J Am Soc Nephrol (2009) 1.08
Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Kidney Int (2005) 1.07
Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat. J Am Soc Nephrol (2007) 1.07
Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis. Nephrol Dial Transplant (2006) 1.06
Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. J Immunol (2008) 1.06
Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6. J Am Soc Nephrol (2007) 1.01
Structural role of glycine in amyloid fibrils formed from transmembrane alpha-helices. Biochemistry (2005) 1.00
Genetic loci modulate macrophage activity and glomerular damage in experimental glomerulonephritis. J Am Soc Nephrol (2010) 0.99
Regulatory T cells are resistant to apoptosis via TCR but not P2X7. J Immunol (2007) 0.98
P2X7 receptor-mediated Nlrp3-inflammasome activation is a genetic determinant of macrophage-dependent crescentic glomerulonephritis. J Leukoc Biol (2012) 0.92
A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome. Blood (2005) 0.92
Is the inflammasome a potential therapeutic target in renal disease? BMC Nephrol (2014) 0.92
Urinary monocyte chemoattractant protein-1 in renal disease. Clin Chim Acta (2011) 0.91
A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis. J Am Soc Nephrol (2009) 0.90
Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses. J Leukoc Biol (2009) 0.89
P2 purinoceptors: Renal pathophysiology and therapeutic potential. Clin Nephrol (2012) 0.88
Sodium and water handling after gastric bypass surgery in a rat model. Surg Obes Relat Dis (2010) 0.88
CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosis. Eur J Clin Invest (2010) 0.87
B-cell-targeted therapy in adult glomerulonephritis. Expert Opin Biol Ther (2013) 0.84
Membrane-microdomain localization of amyloid β-precursor protein (APP) C-terminal fragments is regulated by phosphorylation of the cytoplasmic Thr668 residue. J Biol Chem (2012) 0.84
Urine proteomics and biomarkers in renal disease. Nephron Exp Nephrol (2011) 0.82
Purinergic signaling in inflammatory renal disease. Front Physiol (2013) 0.80
Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis. J Nephrol (2007) 0.80
Keck Foundation Biotechnology Resource Laboratory, Yale University. Yale J Biol Med (2007) 0.80
ATP and arterial calcification. Eur J Clin Invest (2013) 0.79
The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation. Nephrol Dial Transplant (2013) 0.78
Treatment with a cyclin-dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis. Nephrology (Carlton) (2011) 0.78
Effect of IL-11 on glomerular expression of TGF-beta and extracellular matrix in nephrotoxic nephritis in Wistar Kyoto rats. J Nephrol (2010) 0.76
Characterisation of lymphocyte responses to Ca2+ in Scott syndrome. Thromb Haemost (2004) 0.76
Fragmentation of filtered proteins and implications for glomerular protein sieving in Fanconi syndrome. Kidney Int (2002) 0.75
Fostamatinib Disodium. Drugs Future (2011) 0.75